IQVIA’s white paper highlights how generative and agentic AI are driving efficiency and quality in clinical trials. GenAI generates rapid, context-aware responses, while agentic AI executes multi-step processes like monitoring and compliance checks. Safeguards include curated training data, human-in-the-loop oversight, harmonized responses, objectivity, and recognition of knowledge gaps. Use cases show a scientific chatbot cutting protocol query turnaround, AI tools detecting hidden safety risks, and agentic platforms analyzing 400+ risk metrics for real-time oversight. These solutions accelerate trials, reduce errors, and improve compliance, with future advances supported by IQVIA–NVIDIA collaboration.

Join for free to read